We are live on ! Find out more
VM

VV Manager Portfolio holdings

AUM $114M
1-Year Est. Return 59.16%
This Fund
S&P 500
This Quarter Est. Return
+5.15%
1 Year Est. Return
+59.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$233M
AUM Growth
Cap. Flow
+$232M
Cap. Flow %
99.66%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
ALLO icon
Allogene Therapeutics
ALLO
+$204M
2
QTTB icon
Q32 Bio
QTTB
+$16.2M
3
STRO icon
Sutro Biopharma
STRO
+$12M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLO icon
1
Allogene Therapeutics
ALLO
$621M
$207M 88.75%
+7,681,133
New +$204M
QTTB icon
2
Q32 Bio
QTTB
$365M
$17.2M 7.4%
+42,825
New +$16.2M
STRO icon
3
Sutro Biopharma
STRO
$389M
$8.98M 3.85%
+99,558
New +$12M

Similar funds

VV Manager's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for VV Manager, which disclosed 3 positions worth $233M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Allogene Therapeutics: 7,681,133 shares worth $207M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • VV Manager's largest Q4 2018 buy was Allogene Therapeutics: 7,681,133 shares worth $207M.
  • VV Manager's ten largest holdings make up 100% of its $233M portfolio in Q4 2018.
  • VV Manager disclosed 3 positions in Q4 2018, its first 13F filing on record.

Based on VV Manager's 13F filing for Q4 2018, filed 27 Feb 2019.